Drugs / MSCs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02543073 | Sep 2014 → Dec 2017 | bronchiolitis obliterans syndrome, disease related to hematopoietic stem cell transplant | Nanfang Hospital, Southern Medical University | Unknown | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MSCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02543073 ↗ |
| Modality | Cell therapy | “mesenchymal stem cells (MSCs)” NCT02543073 ↗ |